Cannabis News

Goodness Growth Holdings Subsidiary Resurgent Biosciences Receives Patent for Cannabis-Based Moist Snuff Products

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, today announced that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for its subsidiary company Resurgent Biosciences, Inc.'s patent application titled, "Cannabis Based Moist Snuff." This patent covers both the product delivery format and the process for creating a moist snuff from cannabis plants.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) is the new parent company of Vireo Health and Green Goods. (PRNewsfoto/Goodness Growth Holdings)

Cannabis-based snuff products present an opportunity to commercialize a new cannabis product form factor in a delivery format that already has proven appeal to consumers in the multi-billion-dollar tobacco industry, in which moist snuff is the highest selling smokeless product category. The patented process will allow Resurgent Biosciences and its license holders to monetize future cannabis snuff products and brands through the creation of new revenue stream opportunities in both the retail and wholesale sales channels.

"The receipt of this patent highlights the quality and strength of innovation from our team at Resurgent Biosciences, and is consistent with our long-term strategy to develop meaningful, protectable intellectual property and simultaneously disrupt the tobacco industry with safer, cannabis-based alternatives," said Chairman & Chief Executive Officer, Kyle Kingsley , M.D. "We believe cannabis snuff products could have wide appeal to consumers in the future, and we look forward to partnering with organizations who recognize the substantial value these innovations and future generation of products could represent."

Resurgent's patented process will enable the creation of cannabis moist snuff products that will offer consumers a quicker rate of onset and bioavailability than ingested edible products, but at a slower rate of onset than smoking or vaping cannabis. The moist snuff products can be developed with or without various cannabinoids and be created with varying levels of THC, CBD, CBN, and customizable terpene profiles to create varying effects and outcomes for adult-use consumers and medical patients. To learn more about Resurgent Biosciences, please visit https://goodnessgrowth.com/resurgent-biosciences .

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States . For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Contact Information

Investor Inquiries:
Sam Gibbons
Vice President, Investor Relations
samgibbons@goodnessgrowth.com
(612) 314-8995

Media Inquiries:
Albe Zakes
Vice President, Corporate Communications
albezakes@goodnessgrowth.com
(267) 221-4800


Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/goodness-growth-holdings-subsidiary-resurgent-biosciences-receives-patent-for-cannabis-based-moist-snuff-products-301367144.html

SOURCE Goodness Growth Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Trulieve Announces Over 965,000 Signatures for Florida's Smart & Safe Campaign

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the Florida Secretary of State has validated over 965,000 signatures for the Smart & Safe Florida campaign's drive to bring adult use cannabis to Florida . That number represents more than enough to secure ballot placement for the 2024 General Election.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

The initiative, if passed, will allow adult Floridians (ages 21+) to enjoy the freedom to use cannabis products for personal consumption.

Trulieve CEO, Kim Rivers said, "Our investment demonstrates our firm belief that Floridians are ready to experience the freedom to use cannabis for personal consumption; a freedom which is currently enjoyed by more than half of America's adults. With over 965,000 validated signatures from nearly every part of our state, it is clear these voters share that belief. We are thrilled the campaign has made this milestone and look forward to seeing this initiative on the ballot next November."

The next step for the campaign will be to seek approval from the Florida Supreme Court, as required by Florida law and the State Constitution, to ensure the ballot language addresses only one subject and clearly states the chief purpose of the amendment.

Rivers added, "We believe the language, as written, comports with the single subject and clarity requirements under Florida law and look forward to a positive ruling from the Court."

The Florida Supreme Court has published a schedule to begin that process with briefs due from opponents by June 12th and from supporters by July 5th . All amendments to the Florida Constitution must receive 60% of the vote and most published polls show this initiative consistently cresting above 65% among likely Florida voters.

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Nicole Yelland , Executive Director of Corporate Communications
+1 (248) 219-9234
Nicole.Yelland@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-over-965-000-signatures-for-floridas-smart--safe-campaign-301840424.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2023/01/c8408.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow

Plans to Exit Existing U.S. hemp-derived CBD Operations

Intends to Launch Lord Jones ® Brand in the Canadian Adult-use Market in Q4 2023

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, at 1:30PM ET.

A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations .

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
phone showing canadian competition bureau website

Cannabis Weekly Round-Up: Canadian Competition Bureau Calls for Industry Changes

The Canadian cannabis industry needs new THC limits and more relaxed promotional rules in order to thrive, a federal agency said this week in a new report. It also recommends a review of the licensing process.

Meanwhile, a leading multi-state operator enjoyed a jump in share value thanks to its most recent financial report.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Goodness Growth Holdings and Grown Rogue International Announce Strategic Advisory Agreement

Goodness Growth engages Grown Rogue to prioritize improved quality and productivity of its cultivation operations –

– Agreement unites Grown Rogue's cultivation expertise with Goodness Growth's footprint and commitment to its customers for accessible, quality cannabis products –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Creso Pharma

Wholly-Owned Subsidiary, Mernova Medicinal Inc. Continues Strong Progress In Q2 Securing C$593,926 In New Purchase Orders During May

Creso Pharma Limited (ASX:CPH, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to provide the following update on progress through wholly-owned Canadian subsidiary, Mernova Medicinal Inc. (‘Mernova’), which has continued to achieve strong growth in purchase orders in May, as well as an extension of licenses with Health Canada and Canada Revenue Agency.

Keep reading...Show less

Latest Press Releases

Related News

×